Cycloguanil Pamoate in the Treatment and Suppression of Malaria in the Gambia, West Africa
- 19 March 1966
- Vol. 1 (5489) , 695-701
- https://doi.org/10.1136/bmj.1.5489.695
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Cycloguanil Pamoate (CI-501) as a Causal Prophylactic against a Southern Rhodesian Strain of Falciparum MalariaThe American Journal of Tropical Medicine and Hygiene, 1964
- The Effect of a Repository Preparation of the Dihydrotriazine Metabolite of Chlorguanide, CI-501, Against the Chesson Strain of Plasmodium Vivax in ManThe American Journal of Tropical Medicine and Hygiene, 1963
- The Activity of a Repository Form of 4,6-Diamino-1-(p-Chlorophenyl)-1,2-Dihydro-2,2-Dimethyl-s-Triazine against Infections with Plasmodium CynomolgiThe American Journal of Tropical Medicine and Hygiene, 1963
- Laboratory Studies on 4,6-Diamino-1-(p-Chlorophenyl)-1,2-Dihydro-2,2-Dimethyl-s-Triazine Pamoate (CI-501) as a Repository Antimalarial DrugThe American Journal of Tropical Medicine and Hygiene, 1963
- A Metabolite of ‘Paludrine’ with High Antimalarial ActivityNature, 1951